Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $211.27 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $96.44 | 5 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $30.54 | 2 | $0 (2023) |
| GENZYME CORPORATION | $20.94 | 1 | $0 (2023) |
| EMD Serono, Inc. | $17.79 | 1 | $0 (2023) |
| Adaptive Biotechnologies Corporation | $15.78 | 1 | $0 (2024) |
| Pharming Healthcare, Inc. | $15.13 | 1 | $0 (2023) |
| Amgen Inc. | $14.65 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.75 | 4 | ABBVIE INC. ($59.97) |
| 2023 | $85.98 | 5 | GENZYME CORPORATION ($20.94) |
| 2022 | $49.54 | 3 | ABBVIE INC. ($36.47) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: BIOLOGIC | ||||||
| 08/15/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: Oncology | ||||||
| 06/12/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 03/29/2023 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Oncology | ||||||
| 01/09/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
| 12/01/2022 | Taiho Oncology, Inc. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 06/27/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/25/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 78 | 79 | $12,855 | $4,597 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $7,485 | $2,619 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $3,850 | $1,411 | 36.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 14 | 14 | $1,520 | $567.70 | 37.3% |
About Nicole Dillard
Nicole Dillard is a Emergency healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2021. The National Provider Identifier (NPI) number assigned to this provider is 1669139978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Dillard has received a total of $211.27 in payments from pharmaceutical and medical device companies, with $75.75 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($211.27).
As a Medicare-enrolled provider, Dillard has provided services to 78 Medicare beneficiaries, totaling 79 services with total Medicare billing of $4,597. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location Houston, TX
- Active Since 11/22/2021
- Last Updated 09/16/2024
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1669139978
Products in Payments
- ELAHERE (Drug) $46.33
- LONSURF (Drug) $30.54
- JEVTANA (Drug) $20.94
- AVYCAZ (Drug) $18.77
- BAVENCIO (Drug) $17.79
- DALVANCE (Drug) $17.70
- clonoSEQ (Device) $15.78
- RUCONEST (Biological) $15.13
- LUMAKRAS (Drug) $14.65
- EPKINLY (Drug) $13.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Doctors in Houston
Vivian Duong, Fnp-C, FNP-C
Emergency — Payments: $3,045
Ashlye Bryant, Fnp-C, FNP-C
Emergency — Payments: $380.39
Mrs. Braidee Johnson, Aprn- Cnp, APRN- CNP
Emergency — Payments: $362.85
Kariana Dominguez, Np, NP
Emergency — Payments: $353.28
Abigale Darnell
Emergency — Payments: $117.78
Laura Diaz, Fnp-C, FNP-C
Emergency — Payments: $108.88